Not applicableLooking for participantsNCT03796559What this trial is testingMagseed Enabled Long-Term Localization of Axillary Lymph NodesWho this might be right forBreast CancerAxillary Lymph Nodes Endomagnetics Ltd. 65
Not applicableUnknownNCT06097546What this trial is testingSerum Retinoic Acid Induced Protein 14 (RAI14) and Metastasis Associated Cancer Colon -1 (MACC-1) in Breast CancerWho this might be right forBreast Cancer Assiut University 90
Testing effectiveness (Phase 2)Study completedNCT00900627What this trial is testingPhase I/II AZD8931/Paclitaxel in Treatment of Advanced Solid Tumours (Phase I) and Advanced Breast Cancer (Phase II)Who this might be right forNeoplasmsBreast NeoplasmsBreast Cancer AstraZeneca 330
Post-approval studies (Phase 4)WithdrawnNCT02000739What this trial is testingGenetically-informed Therapies for Patients With Metastatic CancerWho this might be right forMetastatic Cancer Dartmouth-Hitchcock Medical Center
Early research (Phase 1)Ended earlyNCT02824575What this trial is testingRebastinib Plus Antitubulin Therapy With Paclitaxel or Eribulin in Metastatic Breast CancerWho this might be right forBreast CancerBreast AdenocarcinomaHuman Epidermal Growth Factor 2 Negative Carcinoma of Breast+2 more Montefiore Medical Center 28
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07647029What this trial is testingA Clinical Study on Prophylactic RespOnse To hEtrombopag for Secondary Prevention in Anti-Cancer Therapy-induced ThrombocytopeniaeWho this might be right forBreast Cancer Patients at High Risk of Chemotherapy-induced Thrombocytopenia (CTIT) Fudan University 126
Not applicableStudy completedNCT02626039What this trial is testingCharacterization & Comparison of Drugable Mutations in Primary and Metastatic Tumors, CTCs and cfDNA in MBCpatientsWho this might be right forMetastatic Breast Cancer Hospital General Universitario Gregorio Marañon 40
Testing effectiveness (Phase 2)Study completedNCT00098605What this trial is testingLapatinib in Treating Brain Metastases in Patients With Stage IV Breast Cancer and Brain MetastasesWho this might be right forCentral Nervous System MetastasesHER2-positive Breast CancerMale Breast Cancer+3 more National Cancer Institute (NCI) 37
Not applicableUnknownNCT04239105What this trial is testingDetection of Circulating Tumor Cells in Breast Cancer Patients Using a Novel Microfluidic and Raman Spectrum DeviceWho this might be right forBreast NeoplasmsCirculating Tumor Cells Xijing Hospital 120
Testing effectiveness (Phase 2)Ended earlyNCT04639245What this trial is testingGenetically Engineered Cells (MAGE-A1-specific T Cell Receptor-transduced Autologous T-cells) and Atezolizumab for the Treatment of Metastatic Triple Negative Breast Cancer, Urothelial Cancer, or Non-small Cell Lung CancerWho this might be right forAnatomic Stage IV Breast Cancer AJCC v8Metastatic Lung Non-Small Cell CarcinomaMetastatic Malignant Solid Neoplasm+3 more Fred Hutchinson Cancer Center 1
Not applicableStudy completedNCT06709937What this trial is testingProspective Multicenter Registry of Patients With Skin Metastases From Breast Cancer Treated With ElectrochemotherapyWho this might be right forBreast Cancer Female Fondazione Policlinico Universitario Agostino Gemelli IRCCS 200
Not applicableStudy completedNCT00003538What this trial is testingPrevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow TransplantationWho this might be right forCancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Large-scale testing (Phase 3)Ended earlyNCT00324324What this trial is testingMoxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell TransplantWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more OHSU Knight Cancer Institute 240
Large-scale testing (Phase 3)Active Not RecruitingNCT02051218What this trial is testingPrevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 WeeksWho this might be right forMetastatic Breast CancerMetastatic Prostate CancerBone Metastases Swiss Cancer Institute 1,380
Not applicableUnknownNCT02966574What this trial is testingMagnetic Resonance Imaging of the Whole Body, Including Diffusion, in the Medical Evaluation of Breast Cancers at High Risk for Metastasis and the Follow-up of Metastatic CancersWho this might be right forMetastatic Breastcancer Brugmann University Hospital 50
Testing effectiveness (Phase 2)Looking for participantsNCT06238921What this trial is testingSacituzumab Govitecan and Zimberelimab w/SRS in the Management of Metastatic Triple Negative Breast Cancer With Brain MetastasesWho this might be right forBreast CancerTriple Negative Breast Cancer H. Lee Moffitt Cancer Center and Research Institute 31
Early research (Phase 1)Study completedNCT01003158What this trial is testingStudy Assessing Safety and Tolerability of AZD8931 Alone or in Combination With Paclitaxel in Japanese Patients.Who this might be right forNeoplasmsMetastatic CancerBreast Cancer AstraZeneca 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT02734290What this trial is testingStandard of Care Chemotherapy Plus Pembrolizumab for Breast CancerWho this might be right forTriple Negative Breast Cancer Providence Health & Services 29
Testing effectiveness (Phase 2)Study completedNCT01216033What this trial is testingExploratory Study of Breast Cancer With ABY025Who this might be right forBreast Cancer Biomedical Radiation Sciences 7
Testing effectiveness (Phase 2)Study completedNCT02052778What this trial is testingTAS-120 in Patients With Advanced Solid TumorsWho this might be right forCholangiocarcinomaUrothelial CancerAdvanced and Metastatic Cancer Patients With Tumors Harboring FGF/FGFR Tumors+3 more Taiho Oncology, Inc. 407